Kenneth C. Frazier
2017
In 2017, Kenneth C. Frazier earned a total compensation of $17.6M as Chairman, President and Chief Executive Officer at Merck & Co., a 19% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $504,658 |
|---|---|
| Non-Equity Incentive Plan | $2,686,575 |
| Option Awards | $3,750,000 |
| Salary | $1,572,212 |
| Stock Awards | $8,814,767 |
| Other | $314,875 |
| Total | $17,643,087 |
Frazier received $8.8M in stock awards, accounting for 50% of the total pay in 2017.
Frazier also received $504.7K of change in pension value and nonqualified deferred compensation earnings, $2.7M in non-equity incentive plan, $3.8M in option awards, $1.6M in salary and $314.9K in other compensation.
Rankings
In 2017, Kenneth C. Frazier's compensation ranked 199th out of 14,666 executives tracked by ExecPay. In other words, Frazier earned more than 98.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 199 out of 14,666 | 99th |
Division Manufacturing | 53 out of 5,768 | 99th |
Major group Chemicals And Allied Products | 14 out of 2,074 | 99th |
Industry group Drugs | 11 out of 1,730 | 99th |
Industry Pharmaceutical Preparations | 10 out of 1,329 | 99th |
Source: SEC filing on April 9, 2018.
Frazier's colleagues
We found four more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2017.
2017
Adam Schechter
Merck & Co.
Executive Vice President and President, Global Human Health
2017
Roger Perlmutter
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2017
Robert Davis
Merck & Co.
Chief Financial Officer
2017
Michael Holston
Merck & Co.